Orgenesis Schedules First Quarter 2021 Business Update Conference Call
May 05 2021 - 7:30AM
Orgenesis Inc. (NASDAQ: ORGS)
(“Orgenesis” or the “Company”), a global biotech company working to
unlock the full potential of cell and gene therapies, today
announced that it plans to host a conference call at 8:30 AM
Eastern Time on Friday, May 7, 2021 to discuss the Company’s
corporate progress and other developments.
The conference call will be available via
telephone by dialing toll free 888-506-0062 for U.S. callers or for
international callers +1 973-528-0011 and using entry code 173027.
A webcast of the call may be accessed at
https://www.webcaster4.com/Webcast/Page/2585/41278 or on the
Company’s Investor Events section of the website here.
A webcast replay will be available on the
Company’s Investor Events section of the website
(https://ir.orgenesis.com/events#/) through Saturday, May 07, 2022.
A telephone replay of the call will be available approximately one
hour following the call, through Friday, May 21, 2021 and can be
accessed by dialing 877-481-4010 for U.S. callers or +1
919-882-2331 for international callers and entering conference ID:
41278.
About OrgenesisOrgenesis is a
global biotech company working to unlock the full potential of
cell and gene therapies (CGTs) in an affordable and accessible
format at the point of care. The Orgenesis
POCare Platform is comprised of three
enabling components: a pipeline of licensed POCare
Therapeutics that are processed and produced in
closed, automated POCare
Technology systems across a
collaborative POCare Network.
Orgenesis identifies promising new therapies and leverages its
POCare Platform to provide a rapid, globally harmonized pathway for
these therapies to reach and treat large numbers of patients at
lowered costs through efficient, scalable, and decentralized
production. The POCare Network brings together patients, doctors,
industry partners, research institutes and hospitals worldwide to
achieve harmonized, regulated clinical development and production
of the therapies. Learn more about the work Orgenesis is doing
at www.orgenesis.com.
Contact for Orgenesis:David
WaldmanCrescendo Communications, LLCTel: 212-671-1021
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Sep 2023 to Sep 2024